Overview

Multicenter Unsustained Tachycardia Trial (MUSTT)

Status:
Completed

Trial end date:
1996-09-01

Target enrollment:

Participant gender:

Summary

To determine the value of electrophysiologic (EP)-guided antiarrhythmic therapy in coronary heart disease patients at increased risk for sudden death. The study included a controlled clinical trial and a registry.

Phase:

Phase 3

Details

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Anti-Arrhythmia Agents